Your browser doesn't support javascript.
loading
Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort.
Maouche, Nadjoua; Kishore, Bhuvan; Bhatti, Zara; Basu, Supratik; Karim, Farheen; Sundararaman, Sharadha; Collings, Freya; Tseu, Bing; Leary, Heather; Ryman, Noel; Reddy, Udaya; Vallance, Grant D; Kothari, Jaimal; Ramasamy, Karthik.
Afiliación
  • Maouche N; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Kishore B; Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Bhatti Z; Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Basu S; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom.
  • Karim F; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom.
  • Sundararaman S; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom.
  • Collings F; Department of Haematology, Great Western Hospitals NHS Foundation Trust, Swindon, United Kingdom.
  • Tseu B; Department of Haematology, Buckinghamshire Healthcare NHS Trust, Bucks, United Kingdom.
  • Leary H; Department of Haematology, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, United Kingdom.
  • Ryman N; Department of Haematology, Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom.
  • Reddy U; Department of Haematology, Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom.
  • Vallance GD; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Kothari J; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Ramasamy K; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
PLoS One ; 17(7): e0270854, 2022.
Article en En | MEDLINE | ID: mdl-35797277
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dexametasona / Bortezomib / Panobinostat / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dexametasona / Bortezomib / Panobinostat / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido